A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia

Nicholas J. Short; Hagop Kantarjian; Elias Jabbour; Jorge E. Cortes; Deborah A. Thomas; Michael E. Rytting; Naval Daver; Yesid Alvarado; Marina Konopleva; Partow Kebriaei; William G. Wierda; Courtney D. DiNardo; Carol Bivins; Deborah McCue; Mary A. Richie; Farhad Ravandi

doi:10.1111/bjh.14806

A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia

Nicholas J. Short
, Hagop Kantarjian
, Elias Jabbour
, Jorge E. Cortes
, Deborah A. Thomas
, Michael E. Rytting
, Naval Daver
, Yesid Alvarado
, Marina Konopleva
, Partow Kebriaei
, William G. Wierda
, Courtney D. DiNardo
, Carol Bivins
, Deborah McCue
, Mary A. Richie
, Farhad Ravandi

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	442-444
Number of pages	3
Journal	British Journal of Haematology
Volume	182
Issue number	3
DOIs	https://doi.org/10.1111/bjh.14806
State	Published - Aug 2018
Externally published	Yes

Keywords

CD22
acute lymphoblastic leukaemia
immunotoxin
moxetumomab pasudotox
relapsed/refractory

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/bjh.14806

Cite this

Short, N. J., Kantarjian, H., Jabbour, E., Cortes, J. E., Thomas, D. A., Rytting, M. E., Daver, N., Alvarado, Y., Konopleva, M., Kebriaei, P., Wierda, W. G., DiNardo, C. D., Bivins, C., McCue, D., Richie, M. A., & Ravandi, F. (2018). A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia. British Journal of Haematology, 182(3), 442-444. https://doi.org/10.1111/bjh.14806

Short, NJ, Kantarjian, H, Jabbour, E, Cortes, JE, Thomas, DA, Rytting, ME, Daver, N, Alvarado, Y, Konopleva, M, Kebriaei, P, Wierda, WG, DiNardo, CD, Bivins, C, McCue, D, Richie, MA & Ravandi, F 2018, 'A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia', British Journal of Haematology, vol. 182, no. 3, pp. 442-444. https://doi.org/10.1111/bjh.14806

@article{b0099d5609764981b11c305455a39c66,

title = "A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia",

keywords = "CD22, acute lymphoblastic leukaemia, immunotoxin, moxetumomab pasudotox, relapsed/refractory",

author = "Short, \{Nicholas J.\} and Hagop Kantarjian and Elias Jabbour and Cortes, \{Jorge E.\} and Thomas, \{Deborah A.\} and Rytting, \{Michael E.\} and Naval Daver and Yesid Alvarado and Marina Konopleva and Partow Kebriaei and Wierda, \{William G.\} and DiNardo, \{Courtney D.\} and Carol Bivins and Deborah McCue and Richie, \{Mary A.\} and Farhad Ravandi",

note = "Funding Information: Supported by Medimmune and the MD Anderson Cancer Center Support Grant CA016672.",

year = "2018",

month = aug,

doi = "10.1111/bjh.14806",

language = "English (US)",

volume = "182",

pages = "442--444",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia

AU - Short, Nicholas J.

AU - Kantarjian, Hagop

AU - Jabbour, Elias

AU - Cortes, Jorge E.

AU - Thomas, Deborah A.

AU - Rytting, Michael E.

AU - Daver, Naval

AU - Alvarado, Yesid

AU - Konopleva, Marina

AU - Kebriaei, Partow

AU - Wierda, William G.

AU - DiNardo, Courtney D.

AU - Bivins, Carol

AU - McCue, Deborah

AU - Richie, Mary A.

AU - Ravandi, Farhad

N1 - Funding Information: Supported by Medimmune and the MD Anderson Cancer Center Support Grant CA016672.

PY - 2018/8

Y1 - 2018/8

KW - CD22

KW - acute lymphoblastic leukaemia

KW - immunotoxin

KW - moxetumomab pasudotox

KW - relapsed/refractory

UR - https://www.scopus.com/pages/publications/85020737884

UR - https://www.scopus.com/pages/publications/85020737884#tab=citedBy

U2 - 10.1111/bjh.14806

DO - 10.1111/bjh.14806

M3 - Letter

C2 - 28616864

AN - SCOPUS:85020737884

SN - 0007-1048

VL - 182

SP - 442

EP - 444

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 3

ER -

A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this